
Sun Pharma to acquire US oncology compony for over Rs 3,000 crore
Sun Pharma, India’s largest drugmaker, is acquiring Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million (over Rs 3,000 crore).The acquisition will bolster the company’s specialty portfolio.Checkpoint is a commercial-stage company that develops novel treatments for patients with solid tumor cancers, and the acquisition includes UNLOXCYT, an FDA-approved treatment for advanced skin…